Optimind Pharma (OMND.CN) Stock Price

Optimind Pharma Price

CSE·CLOSED
0.00
​
Market closed

Revenue at Optimind Pharma has contracted by 16.6% per year over the past 2 years to 118,400.00 CAD. Optimind Pharma's net margin stands at -182.3%, up from -1,809.7% several years earlier.

Optimind Pharma stock price

Access this data via the Eulerpool API

Optimind Pharma business model & stock analysis

Optimind Pharma Corp. provides medical cannabis. The company is headquartered in London, Ontario. The firm helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The firm also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings. Its treatment programs are designed based on scientific research and specific modalities used in many different therapeutic practices. Each treatment program combines the use of psychedelic medicine with therapeutic processing and integration. The company has two different types of treatments. Monotherapy and assisted therapy, all based on a Ketamine capsule. The effects are felt about 30 minutes after, and within two hours of taking the medicine, cognition is resorted to normal.

Frequently asked questions about Optimind Pharma

Converted at the current exchange rate, the Optimind Pharma share trades at 0.00 EUR (0.00 CAD).

The revenue cannot currently be calculated for Optimind Pharma.

The profit cannot currently be calculated for Optimind Pharma.

The P/E ratio cannot be calculated for Optimind Pharma at the moment.

The P/S cannot be calculated for Optimind Pharma currently.

The Eulerpool Quality Score for Optimind Pharma is 3/10.

The ISIN of Optimind Pharma is CA68405U1012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Optimind Pharma is OMND.CN. The ticker symbol is used to trade Optimind Pharma shares on the stock exchange.

Fair ValueTerminal
0.00 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Mar 17, 1998
ISIN
CA68405U1012
Cusip
68405U101
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.86
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-424.80 %
Last updated Oct 10, 2026, 9:37 PM

Optimind Pharma Peer Group

Optimind Pharma Ticker

CNQ · OMND.CN

Optimind Pharma FIGI

OMND:CN · BBG019225TZ5OMND:CF · BBG019225V53OMND:TG · BBG019225VF2OMND:TW · BBG019225VH0OMND:DG · BBG019225VP1OMND:QF · BBG019225VR9OMND:QH · BBG019225VS8OMND:TO · BBG019225VW3OMND:DL · BBG019225VX2OMND:DM · BBG019225VY1OMND:DN · BBG019225W06OMND:QG · BBG019225W15